RLMD
Relmada Therapeutics Inc

1,891
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 06,
After Hours

Estimated EPS

-$0.45

Estimated Rev

$0M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.45
--
--
N/A
Q2 '25
-$0.46
-$0.30
34.78%
BEAT
Q1 '25
-$0.48
-$0.58
-20.83%
MISSED
Q4 '24
-$0.71
-$0.62
12.26%
BEAT
Q3 '24
-$0.68
-$0.72
-6.67%
MISSED

Latest RLMD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.